Comparison of novel oxidative stress and systemic inflammation marker levels in patients with bipolar disorder and schizophrenia

Creative Commons License

Korkmaz Ş. A.

vol.3, no.2, pp.54-55, 2024 (Peer-Reviewed Journal)

  • Publication Type: Article / Editorial Material
  • Volume: 3 Issue: 2
  • Publication Date: 2024
  • Doi Number: 10.51271/ankmj-0011
  • Journal Indexes: TR DİZİN (ULAKBİM)
  • Page Numbers: pp.54-55
  • Çanakkale Onsekiz Mart University Affiliated: Yes

Abstract

Dear Editor,

Bipolar disorder (BD) and schizophrenia (SCZ) are chronic mental disorders with mood and psychotic episodes, respectively, which significantly affect functioning and quality of life. The pathophysiology of both BD and SCZ is still poorly understood; however, accumulating evidence indicates the role of aberrant immune-inflammatory processes.1 The pathophysiological mechanisms of SCZ and BD require further investigation. It is vital to develop a validated methodology that searches for cheap and easily accessible biomarkers and results in an accurate diagnosis.2 A better understanding of the pathophysiology of these chronic mental illnesses is crucial for the discovery of new targets that may lead to better outcomes in their treatment.